Fintel on MSN9h
Piper Sandler Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight Recommendation
Fintel reports that on November 5, 2024, Piper Sandler initiated coverage of Camp4 Therapeutics (NasdaqGM:CAMP) with a Overweight recommendation. Analyst Price Forecast Suggests 173.74% Upside As of ...
Piper Sandler's Schneider: Fiscal policy will likely drive rates higher in either election outcome
Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...